Paget's disease of the breast differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 24: Line 24:
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="4" |Benign or Malignant
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Benign or Malignant
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! colspan="9" |Clinical manifestations
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Clinical manifestations
! colspan="2" rowspan="2" |Para-clinical findings
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Para-clinical findings
| rowspan="4" |Gold Standard
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Gold Standard
| colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors'''
| colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors'''
|-
|-
! colspan="7" rowspan="2" |Symptoms
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Symptoms
! colspan="2" rowspan="2" |Physical examination
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Physical examination
|-
|-
!Lab Findings
!style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
Line 61: Line 61:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
**  
**  
|
|align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | Nl
| align="center" style="background:#F5F5F5;" | Nl
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 69: Line 69:
| align="center" style="background:#F5F5F5;" |Risk factors include
| align="center" style="background:#F5F5F5;" |Risk factors include
* [[Stress]]
* [[Stress]]
* Cold, dry weather can cause flare ups
* Cold, dry weather can cause flare ups
* [[Superinfection]] with bacteria and [[candida]]
* [[Superinfection]] with bacteria and [[candida]]
Generalized seborrheic [[erythroderma]] in immunodeficient patients
Generalized seborrheic [[erythroderma]] in immunodeficient patients
|
|align="center" style="background:#F5F5F5;" |
|
|align="center" style="background:#F5F5F5;" |
|
|align="center" style="background:#F5F5F5;" |
|-
|-
! rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders
! rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]]
|Benign
|align="center" style="background:#F5F5F5;" |Benign
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Epidermal barrier dysfunction
* Epidermal barrier dysfunction
Line 129: Line 128:
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]]
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]]
|
|align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure
Line 135: Line 134:
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent  
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent  
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
|align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Stinging and burning
* Stinging and burning
Line 145: Line 144:
* [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]]  
* [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]]  
* Chronic - [[Hyperkeratosis]] and parakeratosis
* Chronic - [[Hyperkeratosis]] and parakeratosis
|
|align="center" style="background:#F5F5F5;" |
| colspan="2" align="center" style="background:#F5F5F5;" |
| colspan="2" align="center" style="background:#F5F5F5;" |
* Contact with [[allergens]] in the past 1-2 days
* Contact with [[allergens]] in the past 1-2 days
Line 151: Line 150:
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]]
|Benign
|align="center" style="background:#F5F5F5;" |Benign
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Keratinocyte]] hyperproliferation
* [[Keratinocyte]] hyperproliferation
* Dysregulation of the [[immune system]]
* Dysregulation of the [[immune system]]
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales
|
|align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
Line 166: Line 165:
* Extensor surface of elbows and knees
* Extensor surface of elbows and knees
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
|align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Auspitz's sign]]  (pinpoint bleeding)
* [[Auspitz's sign]]  (pinpoint bleeding)
Line 174: Line 173:
* Parakeratosis
* Parakeratosis
* [[Neutrophils]] microabscesses (Munro microabscesses)
* [[Neutrophils]] microabscesses (Munro microabscesses)
|
|align="center" style="background:#F5F5F5;" |
| colspan="2" align="center" style="background:#F5F5F5;" |Risk factors include
| colspan="2" align="center" style="background:#F5F5F5;" |Risk factors include
* [[Smoking]]
* [[Smoking]]
Line 184: Line 183:
|-
|-
![[Melanoma|Malignant melanoma]]
![[Melanoma|Malignant melanoma]]
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
![[Bowen’s disease]]
![[Bowen’s disease]]

Revision as of 16:35, 21 February 2019

Paget's disease of the breast Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paget's disease of the breast from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Biopsy

Ultrasonography

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paget's disease of the breast differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paget's disease of the breast differential diagnosis

CDC on Paget's disease of the breast differential diagnosis

Paget's disease of the breast differential diagnosis in the news

Blogs on Paget's disease of the breast differential diagnosis

Directions to Hospitals Treating Paget's disease of the breast

Risk calculators and risk factors for Paget's disease of the breast differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]

Differential Diagnosis

Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]

Category Diseases rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" Benign or Malignant Etiology colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" Clinical manifestations colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" Para-clinical findings rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" Gold Standard Associated factors
colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" Symptoms colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" Physical examination
Lab Findings Histopathology
Rash Nipple Discharge Erythema Single/

Multiple

Involved areas Mastalgia Breast Exam Other Serum IgE
Eczema
Scalp, face, trunk, postauricular, diaper area and axilla + +
Nl Risk factors include

Generalized seborrheic erythroderma in immunodeficient patients

Skin disorders Atopic dermatitis Benign
  • Epidermal barrier dysfunction
  • Immune dysregulation
Multiple +
  • Young children -Scalp, cheeks amd extensor surface
  • Adolescents -flexural areas and buttock-thigh creases
  • Adults - facial involvement and skin flexures
  • Infra-auricular and retro-auricular fissuring
  • Nipple eczema
  • White dermographism
  • Perifollicular accentuation
  • Epidermal psoriasiform hyperplasia
  • Marked intercellular edema with spongiotic vesiculation
Allergic contact dermatitis[3] Benign Erythematous well-demarcated papules May be multiple after 1-2 days of exposure + Surrounding the area in contact with the offending agent + Nl
Psoriasis Benign Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales + Multiple +
  • Scalp
  • Trunk
  • Gluteal cleft
  • Extensor surface of elbows and knees
+ Nl Risk factors include
Malignant melanoma
Bowen’s disease
Superficial basal cell carcinoma
Pagetoid basal cell carcinoma
Benign intraductal papilloma
Pagetoid dyskeratosis
Lactiferous duct ectasia Benign
  • Distention of subareolar ducts

Ultrasound:

  • Dilated milk ducts
  • Fluid-filled ducts
Nipple duct adenoma
Benign Toker cell hyperplasia
Breast abscess Benign +

Ultrasound:

  • Fluid collection
Mondors disease
Mastitis + ±

Breast parenchymainflammation:

Ultrasound:

  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
Inflammatory Breast Cancer

References

  1. 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
  2. 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
  3. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.